sodium perborate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definition	Drug id	CAS RN
	4777	10332-33-9

Description:

Molecule

Description

Synonyms:

sodium perborate
sodium perborate monohydrate

Molecular weight: 199.62
Formula: B2H4Na2O8
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA:
ALOGS:
ROTB: None

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Gastrointestinal toxicity	203.89	63.94	46	1911	9421	90617069
Pulmonary toxicity	194.86	63.94	46	1911	11485	90615005
Joint injury	147.41	63.94	46	1911	32618	90593872
Neoplasm malignant	145.75	63.94	46	1911	33834	90592656
Hepatotoxicity	132.10	63.94	46	1911	45796	90580694
Joint stiffness	104.98	63.94	45	1912	77997	90548493
Therapy non-responder	86.53	63.94	47	1910	136657	90489833
Musculoskeletal pain	74.12	63.94	46	1911	171205	90455285
Therapeutic product effect incomplete	68.89	63.94	46	1911	193850	90432640
C-reactive protein abnormal	64.84	63.94	38	1919	127391	90499099

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Gastrointestinal toxicity	122.15	65.39	29	1562	11119	110576589
Pulmonary toxicity	108.76	65.39	29	1562	17717	110569991
Neoplasm malignant	87.62	65.39	29	1562	37114	110550594
Joint injury	85.51	65.39	29	1562	39965	110547743
Hepatotoxicity	72.48	65.39	29	1562	63371	110524337
Joint stiffness	67.43	65.39	28	1563	67215	110520493

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	A01AB19	ALIMENTARY TRACT AND METABOLISM STOMATOLOGICAL PREPARATIONS STOMATOLOGICAL PREPARATIONS Antiinfectives and antiseptics for local oral treatment
CHEBI has role	CHEBI:35441	antiinfective agent
CHEBI has role	CHEBI:132717	bleaching agent

Related Drugs by ATC class:

A01AB Antiinfectives and antiseptics for local oral treatment 22 drugs

amphotericin B benzoxonium chloride cetylpyridinium chlorhexidine chlortetracycline clotrimazole domiphen doxycycline hexetidine hydrogen peroxide mepartricin metronidazole show all 22 →

Drug Use | Suggest Off label Use Form| |View source of the data|

None

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

ID	Source
D07066	KEGG_DRUG
4020415	VUID
N0000148205	NUI
7632-04-4	SECONDARY_CAS_RN
4020415	VANDF
CHEBI:30178	CHEBI
CHEMBL3707333	ChEMBL_ID
C027707	MESH_SUPPLEMENTAL_RECORD_UI
Y52BK1W96C	UNII
1991500	RXNORM
NOCODE	MMSL
003159	NDDF
387434009	SNOMEDCT_US
725753000	SNOMEDCT_US
7624002	SNOMEDCT_US
C0074750	UMLSCUI
517072	PUBCHEM_CID

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
Amosan Oral Wound Cleanser Mint	HUMAN OTC DRUG LABEL	1	71223-001	POWDER, FOR SOLUTION	1.20 g	ORAL	OTC Monograph Drug	12 sections
Amosan Oral Wound Cleanser Cherry	HUMAN OTC DRUG LABEL	1	71223-002	POWDER, FOR SOLUTION	1.20 g	ORAL	OTC Monograph Drug	12 sections
Amosan Oral Wound Cleanser Spearmint	HUMAN OTC DRUG LABEL	1	71223-003	POWDER, FOR SOLUTION	1.20 g	ORAL	OTC Monograph Drug	12 sections